|
Anavaj Sakuntabhai MD, PhD ((タイ語:อนวัช ศกุนตาภัย)) is a researcher specialising in human genetics of infectious diseases, notably malaria and dengue. == Career == Anavaj Sakuntabhai began his career as a medical doctor, graduating in 1987. He obtained his PhD in human molecular genetics from the University of Oxford in 1999. In 2000 he joined the Institut Pasteur as a senior scientist and in 2007 became the leader of the laboratory of Genetics of Human Response to Infections. In 2010 he created and became a head of the Functional Genetics of Infectious Diseases Unit.〔 For several years, he was a principal investigator of one of the four consortial projects of the MalariaGEN consortium, a global community of researchers working together to integrate epidemiology with genome science financed by the Bill & Melinda Gates Foundation. He is a partner of a Wellcome Trust financed project on the human genome wide screening for dengue susceptible genes. His laboratory is a principal investigator of a French initiative to tackle the disease burden under changing environments. He is a coordinator of the European FP7 project on Dengue Framework for Resisting Epidemics in Europe (DENFREE). The project aims to find key factors determining dengue transmission and dengue epidemics in order to develop new tools and strategies for controlling dengue transmission. The project also estimates the risk of spreading DENV to uninfected areas, especially in Southern Europe where susceptible vectors exist.〔(【引用サイトリンク】date=25 January 2012 )〕 Sakuntabhai coordinates a global network for dengue research in the Institut Pasteur International Network. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Anavaj Sakuntabhai」の詳細全文を読む スポンサード リンク
|